Pain
Conditions
Brief summary
Allow physicians to test the efficacy of arcoxia in patients with acute pain.
Interventions
Sponsors
Organon and Co
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of acute pain susceptible of pharmacological treatment * Greater than 18 years of age * Voluntary acceptance to participate in the study and signature of the informed consent form
Exclusion criteria
* Allergy to etoricoxib or any of its components * Less than 18 years old * Patient is taking anticoagulants * Patient that already has taken any drug as analgesic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate pain using the verbal analog scale (evaluate pain before starting treatment and then evaluate pain every day after had taken arcoxia up to three days) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction was obtained at the end of treatment(on third day) | — |
| Patient satisfaction with the drug therapy using PGART scale | — |
Outcome results
None listed